1Champion JK, Delise N, Hunt T. Myenteric plexus in spastic motility disorders. J Gastrointest Surg,2001,5: 514-516.
2De Giorgio R, Di Simone MP, Stanghellini V, et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol, 1999, 94:2357-2362.
3Paterson WG. Etiology and pathogenesis of achalasia. Gastrointest Endosc Clin N Am, 2001, 11:249-266.
4Moses PL,Ellis LM,Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut, 2003,52:629-636.
5Singaram C, Sweet MA, Gaumnitz EA, et al. Evaluation of early events in the creation of amyenteric opossum model of achalasia. Neurogastroenterol Motil, 1996, 8:351-361.
6Ervin Y. Eaker,James M. Gordon,Stephen B. Vogel. Case Report: Untoward Effects of Esophageal Botulinum Toxin Injection in the Treatment of Achalasia[J] 1997,Digestive Diseases and Sciences(4):724～727
7H. Bigalke,E. Habermann. Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus[J] 1980,Naunyn - Schmiedeberg’s Archives of Pharmacology(3):255～263
